Short Interest in Ralliant Corporation (NYSE:RAL) Declines By 35.5%

Ralliant Corporation (NYSE:RAL) was the target of a large decrease in short interest in August. As of August 14th, there was short interest totaling 3,692,056 shares, a decrease of 35.5% from the July 30th total of 5,720,042 shares. Based on an average daily volume of 1,479,843 shares, the short-interest ratio is presently 2.5 days. Currently, 3.4% of the shares of the company are sold short.

Ralliant Price Performance

Shares of RAL stock traded up $0.50 during trading hours on Wednesday, hitting $61.53. The company had a trading volume of 157,927 shares, compared to its average volume of 1,650,363. The firm’s fifty day moving average is $68.12 and its 200 day moving average is $56.79. Ralliant has a 12 month low of $37.27 and a 12 month high of $75.41. The firm has a market capitalization of $6.81 billion, a price-to-earnings ratio of -5.67, a PEG ratio of 2.29 and a beta of 1.54. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, sell-side analysts predict that Ralliant will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s payout ratio is presently -1.84%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on RAL shares. Oppenheimer raised their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Wall Street Zen lowered Ralliant from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Evercore began coverage on Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective for the company. Morgan Stanley lifted their price target on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. Finally, Zacks Research upgraded Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $75.70.

Insider Buying and Selling

In other Ralliant news, SVP Karen M. Bick sold 6,062 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president directly owned 31,668 shares in the company, valued at $2,280,096. The trade was a 16.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the transaction, the chief executive officer owned 251,967 shares of the company’s stock, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by company insiders.

Institutional Trading of Ralliant

A number of hedge funds and other institutional investors have recently made changes to their positions in RAL. Dunhill Financial LLC acquired a new stake in Ralliant in the 2nd quarter valued at $25,000. Global Retirement Partners LLC bought a new stake in Ralliant in the 2nd quarter valued at about $35,000. Group One Trading LLC acquired a new position in shares of Ralliant during the 2nd quarter worth approximately $36,000. Danske Bank A S bought a new position in shares of Ralliant during the fourth quarter worth approximately $25,000. Finally, Persistent Asset Partners Ltd bought a new position in shares of Ralliant during the second quarter worth approximately $37,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.